Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Presbyopia treatment raises questions for cataract surgery
  • Presbyopia

Presbyopia treatment raises questions for cataract surgery

Kelsey Moroz

In patients with cataracts who have previously undergone INTRACOR treatment for presbyopia, accurately determining the power of intraocular lenses (IOLs) can be challenging, according to a study.

The study found a tendency toward hyperopic outcomes, potentially affecting visual outcomes post-cataract surgery.

In this interventional case series involving 8 patients (10 eyes),

Patients (N = 8) involved in this interventional case series underwent cataract surgery 6.1 ± 3.2 years after receiving INTRACOR treatment from Technolas Perfect Vision GmbH. Of the 10 eyes included, 9 were implanted with a monofocal IOL, while 1 eye received a small-aperture IOL. The IOL power calculation was based on biometry obtained post-INTRACOR treatment, with additional calculations incorporating keratometry data collected prior to the INTRACOR procedure.

Following cataract surgery, the results showed a mean ± standard deviation (SD) uncorrected distance visual acuity of 0.37 ± 0.17 logMAR, corrected distance visual acuity of 0.10 ± 0.10 logMAR, and manifest refraction spherical equivalent of +0.39 ± 0.63 diopters (D), adjusted to infinity. However, outcomes for intermediate and near visual acuity, both corrected and uncorrected, as well as distance-corrected defocus curves, displayed significant variations across patients.

The study identified a challenge in accurately determining IOL power, particularly using biometry obtained after INTRACOR treatment. Traditional IOL power calculation formulas resulted in hyperopic outcomes, with a mean ± SD prediction error ranging from +0.72 ± 0.34 to +0.96 ± 0.41 D. Even when utilizing keratometry data acquired before INTRACOR, the accuracy improved but remained limited due to substantial variability.

Reference
Naujokaitis T, Hallak MK, Blöck L, et al. Refractive Outcomes of Cataract Surgery in Patients With Intrastromal Femtosecond Laser Treatment of Presbyopia (INTRACOR). J Refract Surg. 2023;39(10):676-682. doi: 10.3928/1081597X-20230831-02. Epub 2023 Oct 1. PMID: 37824299.

Share

Related Content

  • Presbyopia

Smartphone reading habits differ between presbyopic and non-presbyopic adults

  • Presbyopia

Spotlight on TECNIS Odyssey™

  • Presbyopia

Drinking habit associated with faster progression of presbyopia in adults

  • Presbyopia

From readers to topical pharmaceuticals: a new dawn in presbyopia care

  • Presbyopia

Modeling and clinical data align on optimal pupil size for presbyopia therapy

  • Contact Lenses

Women in midlife show larger differences between preferred and full refractive correction

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon